The biological function of death receptor 3 (DR3, TNFR-SF12) is not well characterized. We have discovered recently that DR3 is a critical receptor in the induction of inflammatory lung disease in the murine ovalbumin asthma model. In the murine ovalbumin asthma model DR3 transgenic mice have exaggerated lung inflammation when compared to non transgenic litter mates. In contrast, mice expressing the dominant negative form of DR3 have no lung inflammation, the DR-DN transgene apparently suppresses the lung inflammation normally seen in w.t. mice. To validate this observation we have generated a blocking antibody binding to and blocking TL1A (TNF-SF15), the ligand normally engaging DR3. Antagonistic anti TL1A given during airway ovalbumin challenge to normal ovalbumin primed mice completely blocked the inflammatory lung response seen without antibody or with control antibody. Since newborn mice and children exhibit a striking Th2 bias that upon normal development of the immune system transitions to a Th1 bias in adults, we determined whether new born mice expressed higher levels of DR3 on their T cells than adult mice. This was indeed the case suggesting that DR3 expression is correlated with the Th2 bias of developing mice. We also found that DR3 expression, unlike that of any other member of the TNF-R family, is controlled by alternative mRNA splicing. Resting T cells express no or little DR3 protein but contain high levels of randomly spliced DR3 mRNA. Upon T cell activation via the T cell receptor, protein kinase C (PKC) is activated and mediates correct splicing of full length DR3 and surface expression of the protein. This unique regulation of DR3 expression allows for rapid DR3 protein expression on T cells. In addition it enables environmental regulation of DR3 expression via influencing PKC levels responsible for DR3 splicing and expression. Based on these data we will test the following hypotheses: Hypothesis 1: DR3 signals are major contributors to induction of acute inflammatory lung disease and asthma; DR3 is a critical component of asthma pathogenesis. Hypothesis 2: Neonatal and young mice exhibit a Th2 bias upon T cell activation and express increased levels of DR3 on resting and activated T cells. DR3 expression is causally related to the TH2 bias during development. Hypothesis 3: DR3 expression on resting and activated lymphocytes is controlled by alternative splicing of preformed mRNA; splicing in turn is controlled by protein kinase C. Environmental (infectious) influences can alter DR3 expression via altering of splicing. Hypothesis 4: Atopic asthmatic children exhibit a TH2 bias and express DR3. This will be validated in a Clinical Study.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI061807-04
Application #
7169881
Study Section
Special Emphasis Panel (ZAI1-KLW-I (M6))
Program Officer
Minnicozzi, Michael
Project Start
2004-08-01
Project End
2009-01-31
Budget Start
2007-02-01
Budget End
2008-01-31
Support Year
4
Fiscal Year
2007
Total Cost
$408,521
Indirect Cost
Name
University of Miami School of Medicine
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
052780918
City
Coral Gables
State
FL
Country
United States
Zip Code
33146
Wolf, Dietlinde; Barreras, Henry; Bader, Cameron S et al. (2017) Marked in Vivo Donor Regulatory T Cell Expansion via Interleukin-2 and TL1A-Ig Stimulation Ameliorates Graft-versus-Host Disease but Preserves Graft-versus-Leukemia in Recipients after Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant 23:757-766
Schreiber, Taylor H; Wolf, Dietlinde; Bodero, Maria et al. (2012) T cell costimulation by TNFR superfamily (TNFRSF)4 and TNFRSF25 in the context of vaccination. J Immunol 189:3311-8
Wolf, Dietlinde; Schreiber, Taylor H; Tryphonopoulos, Panagiotis et al. (2012) Tregs expanded in vivo by TNFRSF25 agonists promote cardiac allograft survival. Transplantation 94:569-74
Xiao, Yanping; Motomura, Seiichi; Deyev, Vadim et al. (2011) TNF superfamily member 13, APRIL, inhibits allergic lung inflammation. Eur J Immunol 41:164-71
Fang, Lei; Adkins, Becky; Deyev, Vadim et al. (2008) Essential role of TNF receptor superfamily 25 (TNFRSF25) in the development of allergic lung inflammation. J Exp Med 205:1037-48
Xiao, Yanping; Motomura, Seiichi; Podack, Eckhard R (2008) APRIL (TNFSF13) regulates collagen-induced arthritis, IL-17 production and Th2 response. Eur J Immunol 38:3450-8
Nam, Sang-Yun; Kim, Young-Hyun; Do, Jeong-Su et al. (2008) CD30 supports lung inflammation. Int Immunol 20:177-84
Podack, Eckhard R; Deyev, Vadim; Shiratsuchi, Motoaki (2007) Pore formers of the immune system. Adv Exp Med Biol 598:325-41
Oizumi, Satoshi; Strbo, Natasa; Pahwa, Savita et al. (2007) Molecular and cellular requirements for enhanced antigen cross-presentation to CD8 cytotoxic T lymphocytes. J Immunol 179:2310-7